Pharmaceutical Technology's In the Lab eNewsletter
A new scientific publication examines analytical processes for the emerging legal cannabis industry.
As FDA weighs initial approvals of cannabinoid-based treatments, a growing number of states have legalized marijuana for medicinal and recreational use. Compared with the regulated pharmaceutical environment, the legal cannabis industry is subject to varying state regulations; analytical and quality control guidelines are often lacking.
To fill this gap, a new professional journal and website, Cannabis Science and Technology, was launched in March 2018, in alliance with the Cannabis Science Conference, to educate the legal cannabis industry about the science and technology of analytical testing and quality control.
The publication-a sister publication to Pharmaceutical Technology-will focus on sample preparation techniques for analytical testing; development of analytical methods for potency testing; identification of contaminants such as pesticides, residual solvents, heavy metals, and mycotoxins; quality control for cannabis, extraction, and processing; laboratory best practices and certification; testing standardization; and regulations related to quality control.
The first issue features articles on quality assurance, laboratory accreditation, analytical tools to analyze edibles, metals analysis, and extraction processes. The first issue and subscription information are available on the publication’s website.
Inquiries about editorial submissions can be sent to Meg L’Heureux, Editor-in-Chief.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy
March 25th 2025Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.